Bristol-Myers Squibb Company (BMY) Balance Sheet

	FY25	FY24	FY23	FY22	FY21	FY20	YoY
Assets
Current Assets	$29.4B	$29.8B	$31.8B	$27.3B	$33.3B	$30.2B	-1.3%
Inventories	$2.7B	$2.6B	$2.7B	$2.3B	$2.1B	$2.1B	+5.2%
Trade Receivables	$9.6B	$9.0B	$8.9B	$8.2B	$8.0B	$7.2B	+6.4%
Cash & Equivalents	$10.2B	$10.3B	$11.5B	$9.1B	$14.0B	$14.5B	-1.3%
Property, Plant & Equipment	$7.5B	$7.1B	$6.6B	$6.3B	$6.0B	$5.9B	+5.7%
Goodwill	$21.8B	$21.7B	$21.2B	$21.1B	$20.5B	$20.5B	+0.2%
Intangible Assets	$19.1B	$23.3B	$27.1B	$35.9B	$42.5B	$53.2B	-18.0%
Deferred Tax Assets	$5.4B	$4.2B	$2.8B	$1.3B	$1.4B	$1.2B	+27.0%
Total Assets	$90.0B	$92.6B	$95.2B	$96.8B	$109.3B	$118.5B	-2.8%
Liabilities
Current Liabilities	$23.4B	$23.8B	$22.3B	$21.9B	$21.9B	$19.1B	-1.5%
Trade Payables	$3.6B	$3.6B	$3.3B	$3.0B	$2.9B	$2.7B	-0.7%
Borrowings	$44.8B	$49.4B	$39.5B	$39.0B	$44.4B	$50.3B	-9.3%
Deferred Tax Liabilities	$222.0M	$369.0M	$338.0M	$2.2B	$4.5B	$5.4B	-39.8%
Total Liabilities	$71.5B	$76.2B	$65.7B	$65.7B	$73.3B	$80.6B	-6.1%
Equity
Share Capital	—	—	—	$292.0M	$292.0M	$292.0M	—
Share Premium	$46.4B	$46.0B	$45.7B	$45.2B	$44.4B	$44.3B	+0.8%
Retained Earnings	$16.9B	$14.9B	$28.8B	$25.5B	$23.8B	$21.3B	+13.3%
Minority Interests	$33.0M	$53.0M	$55.0M	$57.0M	$60.0M	$60.0M	-37.7%
Total Equity	$18.5B	$16.4B	$29.5B	$31.1B	$36.0B	$37.9B	+12.9%

New to Ticker

Create a free Ticker account to see every line of the income statement, balance sheet and cash flow, plus dividends and financial health.

Bristol-Myers Squibb Company — Balance Sheet